Title | Generation of High Dose Inhalable Effervescent Dispersions against Pseudomonas aeruginosa Biofilms |
---|
Type | Journal article |
---|
Authors | Mohammed, Aram, Zurek, Jakub, Madueke, Somto, Al-Kassimy, Hareir, Yaqoob, Muhammad, Houacine, Chahinez, Ferraz, Amina, Kalgudi, Rachith, Zariwala, Mohammed Gulrez, Hawkins, Nicholas and Al-Obaidi, H. |
---|
Abstract | Novel particle engineering approach was used in this study to generate high dose inhalable effervescent particles with synergistic effects against Pseudomonas aeruginosa biofilms. Spray dried co-amorphous salt of ciprofloxacin (CFX) and tartaric acid (TA) was prepared and coated with external layer of sodium bicarbonate and silica coated silver nanobeads. Design of experiments (DOE) was used to optimize physicochemical properties of particles for enhanced lung deposition. Generated particles were co-amorphous CFX/TA showing that CFX lost its zwitterionic form and exhibiting distinct properties to CFX/HCl as assessed by FTIR and thermal analysis. Particles exhibited mass mean aerodynamic diameter (MMAD) of 3.3 μm, emitted dose of 78% and fine particle dose of 85%. Particles were further evaluated via antimicrobial assessment of minimum inhibitory concentrations (MIC) and minimum biofilm eradication concentration (MBEC). MIC and MBEC results showed that the hybrid particles were around 3-5 times more effective when compared to CFX signifying that synergistic effect was achieved. Diffusing wave spectroscopy results showed that the silver containing particles had a disruptive effect on rheological properties as opposed to silver free particles. Overall, these results showed the potential to use particle engineering to generate particles that are highly disruptive of bacterial biofilms. |
---|
Keywords | Co-amorphous |
---|
| Pseudomonas aeruginosa |
---|
| ciprofloxacin |
---|
| dry powder inhaler |
---|
| effervescent |
---|
Journal | Pharmaceutical Research |
---|
Journal citation | 37 (8), p. 150 |
---|
ISSN | 1573-904X |
---|
Year | 2020 |
---|
Publisher | Springer |
---|
Publisher's version | License CC BY 4.0 File Access Level Open (open metadata and files) |
---|
Digital Object Identifier (DOI) | https://doi.org/10.1007/s11095-020-02878-w |
---|
PubMed ID | 32686026 |
---|
Publication dates |
---|
Published online | 19 Jul 2020 |
---|